Publikationen, an denen er mitarbeitet JON CACICEDO FERNANDEZ DE BOBADILLA (18)

2019

  1. Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study

    Radiotherapy and Oncology, Vol. 135, pp. 13-18

  2. Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT

    European Journal of Cancer Care, Vol. 28, Núm. 5

2018

  1. Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

    Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584

  2. Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial

    Radiotherapy and Oncology, Vol. 126, Núm. 2, pp. 278-282

  3. Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 101, Núm. 5, pp. 1172-1178

2017

  1. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1337-1349

2016

  1. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist

    British Journal of Radiology, Vol. 89, Núm. 1067

  2. Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy

    Journal of Contemporary Brachytherapy, Vol. 8, Núm. 6, pp. 477-483

2015

  1. Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: Multicenter prospective observational study

    BMC Palliative Care, Vol. 14, Núm. 1

  2. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 9, pp. 1378-1389

2014

  1. A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy

    Chinese Journal of Cancer, Vol. 33, Núm. 4, pp. 204-210

  2. A prospective analysis of inter- and intrafractional errors to calculate CTV to PTV margins in head and neck patients

    Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 113-120

  3. Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy

    Journal of Contemporary Brachytherapy, Vol. 6, Núm. 2, pp. 154-160

  4. Stereotactic body radiotherapy: An attractive treatment modality for recurrent head and neck carcinoma. (Regarding Lartigau et al.: Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer)

    Radiotherapy and Oncology

  5. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach

    Cancer Treatment Reviews, Vol. 40, Núm. 1, pp. 178-189

2013

  1. Definitive radiotherapy for T1 glottic squamous cell carcinoma: A 15-year Cruces University Hospital experience

    Clinical and Translational Oncology, Vol. 15, Núm. 11, pp. 925-931

2012

  1. Detection of risk factors that influence weight loss in patients undergoing radiotherapy

    Reports of Practical Oncology and Radiotherapy, Vol. 17, Núm. 5, pp. 269-275

  2. Smartphones and tablets: Reshaping radiation oncologists' lives

    Reports of Practical Oncology and Radiotherapy, Vol. 17, Núm. 5, pp. 276-280